You are viewing: South Korea ECMO Machines Market analysis
Part of: ECMO Machines Market (Global)

The South Korea ECMO Machines Market was valued at $8.74 Million in 2025 and projected to reach to $12.03 Million by 2030, representing a compound annual growth rate of 6.6%. South Korea's ECMO machines market is poised for sustained growth through 2030, driven by the nation's aging population, rising incidence of cardiac and pulmonary conditions, and continuous investment in critical care infrastructure.

South Korea ECMO Machines Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea ECMO Machines Market Trends and Insights

  • This represents a compound annual growth rate (CAGR) of 6.6%, outpacing global averages and reflecting South Korea's advanced healthcare infrastructure and increasing adoption of critical care technologies.
  • The market expansion in South Korea is driven by rising prevalence of cardiac and respiratory failures, coupled with the nation's strong emphasis on innovative medical device adoption. South Korea's healthcare system, characterized by high spending and technological advancement, continues to invest in extracorporeal membrane oxygenation (ECMO) capabilities across major hospitals and specialized cardiac centers.
  • Between 2025 and 2030, South Korea is expected to see increased deployment of ECMO systems in both adult and pediatric settings, supported by growing clinical evidence and reimbursement improvements.
  • South Korea's aging population and rising incidence of cardiovascular diseases further accelerate demand for life-support technologies, positioning the country as a key growth market within the Asia Pacific region..

Key Market Statistics

  • CAGR (2025-2030) 6.6% CAGR
  • Market Size, 2025 ~USD 8.74 Million
  • Forecast, 2030 ~USD 12.03 Million
  • Country South Korea

South Korea ECMO Machines Market Overview

Market Valuation & Growth :

South Korea's ECMO machines market is valued at USD 8.74 million in 2025, with a projected expansion to USD 12.03 million by 2030, representing a robust 6.6% CAGR that exceeds global growth rates.

Advanced Healthcare Infrastructure :

South Korea's sophisticated medical technology ecosystem and high healthcare spending per capita drive rapid adoption of extracorporeal membrane oxygenation systems in tertiary care centers and specialized cardiac facilities.

Critical Care Demand :

Increasing prevalence of cardiovascular diseases, respiratory complications, and post-COVID recovery needs have elevated demand for ECMO support systems across South Korean hospitals and intensive care units.

Technological Innovation Hub :

South Korea's position as a global medical device innovator, combined with strong government support for healthcare R&D, accelerates the development and deployment of next-generation ECMO technologies.

South Korea ECMO Machines Market Dynamics

  • The country's advanced healthcare system and high adoption rates of cutting-edge medical technologies create a favorable environment for ECMO device manufacturers and service providers.
  • Government initiatives promoting healthcare modernization and increased hospital budgets for life-support equipment further support market expansion.
  • South Korean hospitals' emphasis on patient outcomes and survival rates in critical conditions continues to drive ECMO adoption across major medical centers and regional facilities..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • South Korea's ECMO machines market is valued at USD 8.74 million in 2025 and is forecast to reach USD 12.03 million by 2030.
    • South Korea demonstrates a 6.6% CAGR, exceeding the global average of 5.8%, indicating accelerated market penetration.
    • South Korea's advanced healthcare infrastructure and aging demographics drive increased adoption of ECMO technology in critical care settings.
    • South Korea's market growth is supported by improved reimbursement policies and expanding clinical applications in both cardiac and respiratory care.

    ECMO Machines Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.8% from 2025 to 2030
    Largest Segment ADULT PATIENTS (Patient Type)
    Market Size Base Year (Billions) ~USD 0.65 (2025)
    Revenue Forecast (Billions) ~USD 0.86 (2030)
    Segments Covered Product, Type, Modality, Patient Type, Application, End User

    South Korea ECMO Machines Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Components
    • Machines

    By Type

    • Accessories
    • Cannulas
    • Controllers
    • Oxygenators
    • Pumps

    By Modality

    • Arteriovenous Ecmo
    • Venoarterial Ecmo
    • Venovenous Ecmo

    By Patient Type

    • Adult Patients
    • Neonates
    • Pediatric Patients

    By Application

    • Cardiac Applications
    • Extracorporeal Cardiopulmonary Resuscitation (Ecpr)
    • Respiratory Applications

    By End User

    • Academic & Research Institutions
    • Hospitals
    • Specialty Clinics

    Target Audience

    • Medical Device Manufacturers : ECMO equipment producers need South Korea-specific market data to identify growth opportunities, assess competitive positioning, and develop localized product strategies for this high-tech healthcare market.
    • Healthcare Investors & PE Firms : Investment professionals require detailed South Korea market analysis to evaluate portfolio opportunities, assess growth potential, and make informed capital allocation decisions in the critical care segment.
    • Hospital Administrators & Procurement Teams : South Korean hospital leaders need market intelligence on ECMO technology trends, vendor options, and cost-benefit analyses to optimize critical care capabilities and budget allocation.
    • Healthcare Consultants & Advisors : Consulting firms advising healthcare organizations require South Korea-specific market data to develop strategic recommendations, competitive analyses, and technology adoption roadmaps.
    • Regulatory & Policy Makers : Government health agencies and policy officials need market insights to inform healthcare infrastructure planning, reimbursement policies, and critical care technology standards in South Korea.

    Key Companies in the South Korea ECMO Machines Market

    CompanyHQOwnershipStrongest segments
    GETINGESwedenPublic CompanyAcute Care Therapies,Surgical Workflows,Life Science,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
    FRESENIUS MEDICAL CARE AGGermanyPublic CompanyDialysis services (outpatient and in-hospital ESRD/acute),Dialysis machines, cyclers, and water treatment systems,Dialysis consumables and solutions,
    LIVANOVA PLCUnited KingdomPublic CompanyCardiopulmonary (heart-lung machines, oxygenators, autotransfusion, perfusion tubing, cannula, services),Neuromodulation (VNS Therapy for epilepsy and depression, aura6000 development),
    NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products, functional products,Pharmaceutical-Related (CDMO for injectables and oral drugs, kit products),
    WEIGAO GROUP CO., LTD.ChinaPublic CompanyMedical Device Products (infusion, clinical nursing, perioperative, urinary, rehab, extracorporeal circulation),Orthopedic Products (spine, joint, trauma, sports medicine, bone repair, spinal endoscope),Pharma Packaging Products (prefilled systems, packaging consumables, automatic drug delivery),
    ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
    MICROPORT SCIENTIFIC CORPORATIONChinaPublic CompanyCardiovascular Devices,Orthopedics Devices,Cardiac Rhythm Management,

    GETINGE

    Getinge is a Swedish public company founded in 1904 that employs 11,754 people and operates in the medical technology sector.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees specializing in medical devices and healthcare solutions.

    TERUMO CORPORATION

    Terumo Corporation is a Japanese public company established in 1921 with 30,591 employees, operating in the medical device and healthcare industry.

    FRESENIUS MEDICAL CARE AG

    Fresenius Medical Care AG is a German public company founded in 1996 with 108,165 employees, providing dialysis and renal care services globally.

    LIVANOVA PLC

    LivaNova PLC is a United Kingdom-based public company founded in 2015 with 3,300 employees, focused on neuromodulation and cardiac surgery solutions.

    NIPRO

    Nipro is a Japanese public company established in 1947 with 38,593 employees, manufacturing medical devices and pharmaceutical products.

    WEIGAO GROUP CO., LTD.

    Weigao Group Co., Ltd. is a Chinese public company founded in 1988 with 13,307 employees, specializing in medical device manufacturing.

    ABBOTT

    Abbott is a United States-based public company founded in 1888 with 115,000 employees, operating across diagnostics, medical devices, nutrition, and pharmaceuticals.

    MICROPORT SCIENTIFIC CORPORATION

    MicroPort Scientific Corporation is a Chinese public company established in 1998 with 6,547 employees, developing and manufacturing medical devices.

    Reasons to Buy this Report

    • Market-Specific Growth Insights : Gain detailed understanding of South Korea's 6.6% CAGR trajectory, outpacing global averages and identifying high-growth opportunities within the region's healthcare sector.
    • Competitive Landscape Analysis : Understand key players, market share distribution, and competitive strategies specific to South Korea's ECMO market, enabling informed business decisions and partnership opportunities.
    • Regulatory & Reimbursement Framework : Access South Korea-specific regulatory requirements, healthcare reimbursement policies, and government initiatives that directly impact ECMO device adoption and market dynamics.
    • Hospital & Healthcare Provider Insights : Identify major South Korean hospitals, cardiac centers, and ICU facilities driving ECMO adoption, including their procurement patterns and technology preferences.
    • Strategic Market Entry Planning : Develop targeted market entry strategies for South Korea with localized insights on customer needs, distribution channels, and growth acceleration opportunities through 2030.

    Frequently asked questions

    What is the current market size of ECMO machines in South Korea?

    South Korea's ECMO machines market is valued at USD 8.74 million in 2025, with verified data from KS table sources.

    What is the projected market size for ECMO machines in South Korea by 2030?

    South Korea's ECMO machines market is forecast to reach USD 12.03 million by 2030, representing significant growth over the five-year period.

    What is the CAGR for South Korea's ECMO machines market?

    South Korea's ECMO machines market is growing at a CAGR of 6.6% from 2025 to 2030, outpacing the global CAGR of 5.8%.

    What factors are driving growth in South Korea's ECMO market?

    South Korea's ECMO market growth is driven by an aging population, rising cardiovascular disease prevalence, advanced healthcare infrastructure, and improved reimbursement policies.

    How does South Korea's ECMO market compare to global trends?

    South Korea's 6.6% CAGR exceeds the global average of 5.8%, reflecting stronger market adoption and healthcare investment in the country.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size of the ECMO machines market. Exhaustive secondary research was done to collect information on the ECMO market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ECMO market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ECMO market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the ECMO market. Primary sources from the demand side included hospitals, academic & research institutions, specialty clinics, researchers, lab technicians, purchase managers, and stakeholders in corporate & government bodies.

    The following is a breakdown of the primary respondents:

    ECMO Machines Market

    Note 1: C-level primaries include CEOs, COOs, and CTOs.

    Note 2: Others include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ECMO market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    ECMO Machines Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ECMO machines and components. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    An ECMO machine acts as an artificial heart and lung for a patient whose heart or lungs cannot provide enough blood flow or oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of ECMO is to let the heart and lungs recover while the patient is supported by the ECMO machine.

    Stakeholders

    • Manufacturers of ECMO Machine Products and Related Devices
    • Suppliers and Distributors of ECMO Machine Devices
    • Hospitals, Clinics, and Medical Colleges
    • Medical Device Procurement Agencies
    • Government Bodies/Municipal Corporations
    • Business Research and Consulting Service Providers
    • Venture Capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the oxygen concentrators market based on product, modality, patient type, application, end user, and region  
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall oxygen concentrators market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the oxygen concentrators market in six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East & Africa, and GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full ECMO Machines Market Report

    Full forecast, segment splits, and company analysis for all ECMO Machines Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status